Status:
COMPLETED
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
Lead Sponsor:
Pfizer
Conditions:
Small For Gestational Age (SGA)
Eligibility:
All Genders
4+ years
Brief Summary
The purpose of this protocol is to retrospectively study the influence of age at start of growth hormone (GH) treatment on height gain in children born small for gestational age (SGA).
Eligibility Criteria
Inclusion
- SGA children.
- Treated with GH at least 36 months.
Exclusion
- Patients treated with GH for other indications (not SGA).
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT01897753
Start Date
March 1 2012
End Date
September 1 2013
Last Update
January 20 2014
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Germans Trias i Pujol
Badalona, Barcelona, Spain, 8916
2
Capio H.Universitario Sagrat Cor
Barcelona, Barcelona, Spain, 8029
3
H. Vall d'Hebron
Barcelona, Barcelona, Spain, 8035
4
H. Sant Joan de Déu
Esplugues de Llobregat, Barcelona, Spain, 8950